CL2017000153A1 - Composiciones de azúcares para la formación de comprimidos mediante compresión directa - Google Patents

Composiciones de azúcares para la formación de comprimidos mediante compresión directa

Info

Publication number
CL2017000153A1
CL2017000153A1 CL2017000153A CL2017000153A CL2017000153A1 CL 2017000153 A1 CL2017000153 A1 CL 2017000153A1 CL 2017000153 A CL2017000153 A CL 2017000153A CL 2017000153 A CL2017000153 A CL 2017000153A CL 2017000153 A1 CL2017000153 A1 CL 2017000153A1
Authority
CL
Chile
Prior art keywords
tabletting
direct compression
sugar compositions
compositions
sugar
Prior art date
Application number
CL2017000153A
Other languages
English (en)
Inventor
Baptiste Boit
Pierre Lanos
Fabrice Buquet
Original Assignee
Roquette Freres
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roquette Freres filed Critical Roquette Freres
Publication of CL2017000153A1 publication Critical patent/CL2017000153A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
    • A23L27/30—Artificial sweetening agents
    • A23L27/33—Artificial sweetening agents containing sugars or derivatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/30—Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
    • A23P10/00—Shaping or working of foodstuffs characterised by the products
    • A23P10/20—Agglomerating; Granulating; Tabletting
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
    • A23P10/00—Shaping or working of foodstuffs characterised by the products
    • A23P10/20—Agglomerating; Granulating; Tabletting
    • A23P10/25—Agglomeration or granulation by extrusion or by pressing, e.g. through small holes, through sieves or between surfaces
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
    • A23P10/00—Shaping or working of foodstuffs characterised by the products
    • A23P10/20—Agglomerating; Granulating; Tabletting
    • A23P10/28—Tabletting; Making food bars by compression of a dry powdered mixture
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Mycology (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Neurology (AREA)
  • Toxicology (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Biomedical Technology (AREA)
  • Obesity (AREA)
  • Neurosurgery (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Seasonings (AREA)

Abstract

<p>LA PRESENTE INVENCIÓN SE REFIERE A COMPOSICIONES DIRECTAMENTE COMPRESIBLES QUE COMPRENDEN MÁS DE 30 % EN PESO DE ALULOSA, Y A COMPRIMIDOS OBTENIBLES A PARTIR DE LAS MISMAS.</p>
CL2017000153A 2014-07-21 2017-01-19 Composiciones de azúcares para la formación de comprimidos mediante compresión directa CL2017000153A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP14306181 2014-07-21

Publications (1)

Publication Number Publication Date
CL2017000153A1 true CL2017000153A1 (es) 2017-07-28

Family

ID=51265637

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2017000153A CL2017000153A1 (es) 2014-07-21 2017-01-19 Composiciones de azúcares para la formación de comprimidos mediante compresión directa

Country Status (11)

Country Link
US (3) US20170208849A1 (es)
EP (1) EP3171709B1 (es)
JP (1) JP6731400B2 (es)
KR (1) KR102557664B1 (es)
CN (1) CN106659225B (es)
BR (1) BR112017001000B1 (es)
CA (1) CA2955845C (es)
CL (1) CL2017000153A1 (es)
MX (1) MX2017000829A (es)
SG (1) SG11201700445YA (es)
WO (1) WO2016012853A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105148280A (zh) * 2015-07-07 2015-12-16 深圳国源国药有限公司 一种创新药用辅料可压性蔗糖及其制备方法
FR3061413B1 (fr) 2017-01-05 2021-08-27 Roquette Freres Procede de fabrication de cristaux de d-allulose
US10925853B2 (en) * 2019-04-17 2021-02-23 Nordiccan A/S Oral cannabinoid tablet
US20230172244A1 (en) * 2020-04-30 2023-06-08 Firmenich Sa Flavor particle
EP4000419A1 (de) 2020-11-23 2022-05-25 Savanna Ingredients GmbH Trocknung von allulosekristallen

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3305447A (en) 1963-06-12 1967-02-21 American Sugar Tabletting sugar and method of preparing same
US3627583A (en) 1969-04-29 1971-12-14 Sucrest Corp Direct compression vehicles
US4698101A (en) * 1982-08-30 1987-10-06 Suomen Sokeri Oy (Finnish Sugar Company Ltd.) Binder-diluent composition and method
FI104787B (fi) 1989-06-07 2000-04-14 Xyrofin Oy Fruktoosipohjainen rakeistettu tuote ja menetelmä sen valmistamiseksi
ES2292414T3 (es) * 2000-07-27 2008-03-16 Roquette Freres Granulos a base de almidon y de lactosa.
EP2364710B1 (en) * 2002-05-22 2018-11-28 National University Corporation Kagawa University Therapeutic use of D-allose
WO2005060937A1 (en) * 2003-12-23 2005-07-07 Chr. Hansen A/S Compressed tablets comprising viable probiotic microorganisms
JP4761424B2 (ja) 2004-03-17 2011-08-31 株式会社希少糖生産技術研究所 Ｌ−プシコース結晶、その製造方法および、糖試薬キット
US20080221044A1 (en) 2004-05-26 2008-09-11 National University Corporation Kagawa University Composition for Inhibiting the Onset of Arteriosclerosis and Inhibition Method
WO2006101118A1 (ja) * 2005-03-23 2006-09-28 National University Corporation Kagawa University D-プシコースの血糖値日内異常上昇抑制の用途
JP5116071B2 (ja) * 2005-07-20 2013-01-09 帝國製薬株式会社 Ｄ−アロースおよびｄ−プシコースの抗神経因性疼痛効果の利用
EP2090180A4 (en) 2006-11-10 2013-08-21 Matsutani Kagaku Kogyo Kk SWEETENER CONTAINING D-PSICOSE AND FOODS AND BEVERAGES OBTAINED USING THE SAME
US20100130435A1 (en) 2006-11-17 2010-05-27 National University Corporation Kagawa University Utilization of the function of rare sugar as promoter for the migration of glucokinase from nucleus to cytoplasm
KR20150015030A (ko) 2007-05-18 2015-02-09 마쓰다니가가꾸고오교가부시끼가이샤 슈크로오스성 감미질을 가지는 신규 감미료, 그 제조법 및 용도
FR2925499B1 (fr) * 2007-12-20 2010-02-12 Roquette Freres Maltitol granule pour compression directe et son procede de preparation
JP5859191B2 (ja) * 2010-09-29 2016-02-10 松谷化学工業株式会社 高甘味度甘味料に対する呈味改良組成物およびその応用
JP6216493B2 (ja) * 2011-06-24 2017-10-18 国立大学法人 香川大学 寿命延長剤
CN102697744B (zh) * 2012-05-29 2013-11-27 安吉东来药用辅料有限责任公司 阿洛糖片剂赋形剂、药物片剂及药物片剂的制备方法
WO2014175119A1 (ja) * 2013-04-26 2014-10-30 松谷化学工業株式会社 エネルギー消費の促進および／またはエネルギー消費機能低下の治療および／または予防剤、または方法

Also Published As

Publication number Publication date
WO2016012853A1 (en) 2016-01-28
JP2017522032A (ja) 2017-08-10
CA2955845C (en) 2022-08-16
US20170208849A1 (en) 2017-07-27
KR20170030524A (ko) 2017-03-17
CA2955845A1 (en) 2016-01-28
BR112017001000B1 (pt) 2021-11-30
US20220240560A1 (en) 2022-08-04
JP6731400B2 (ja) 2020-07-29
CN106659225A (zh) 2017-05-10
CN106659225B (zh) 2021-04-02
US11350658B2 (en) 2022-06-07
BR112017001000A2 (pt) 2017-11-14
EP3171709B1 (en) 2024-09-04
SG11201700445YA (en) 2017-02-27
US20190090528A1 (en) 2019-03-28
US11986002B2 (en) 2024-05-21
MX2017000829A (es) 2017-05-01
KR102557664B1 (ko) 2023-07-20
EP3171709A1 (en) 2017-05-31

Similar Documents

Publication Publication Date Title
CL2017000136A1 (es) Composiciones de azúcar para la formación de comprimidos por compresión directa
SA519401180B1 (ar) مركبات بيروليزين بها استبدال واستخداماتها
CU20180001A7 (es) Derivados de oxopiridina sustituidos y procesos para su preparación
CL2017000153A1 (es) Composiciones de azúcares para la formación de comprimidos mediante compresión directa
GT201600147A (es) Compuestos derivados y composiciones de n-azaspirocicloalcano n-heteroaril sustituido para inhibir la actividad de shp2
EA201691259A1 (ru) РЕГУЛЯТОРЫ Nrf2
UY33735A (es) Compuestos antivirales
ECSP17064695A (es) Compuestos y composiciones de alfa-cinamida como inhibidores de hdac8
CO2018003452A2 (es) Anticuerpos biespecíficos contra el cd20 humano y el receptor de transferrina humano y métodos de uso
EA201691582A1 (ru) Новые фармацевтические препараты
CR20150370A (es) Compuestos antivirales
GT201400102A (es) 4-fenil-piridinas sustituidas para el tratamiento de enfermedades relacionadas con el receptor de nk1
EA201690372A1 (ru) Азапиридоновые соединения и их применение
CO2018001840A2 (es) Composiciones biofarmacéuticas que comprenden anticuerpos anti-il-5
BR112018011526A2 (pt) compostos policíclicos como inibidores da tirosina quinase de bruton
EA201692043A1 (ru) Лекарственная форма иммунодепрессанта
DOP2016000212A (es) Heterociclos condensados sustituidos como moduladores de gpr119 para el tratamiento de la diabetes, obesidad, dislipidemia y trastornos relacionados
GT201500247A (es) Imidazopiridazinas sustituidas
PH12017500304A1 (en) Vaccine compositions against dengue virus diseases
MX2018015410A (es) Esteres de oxaborol y sus usos.
GT201600252A (es) Derivados de naftiridinadiona
TR201901516T4 (tr) Nöroprotektif ajanlar ve bunların kullanımları.
UY34595A (es) Composición farmacéutica de liberación prolongada de trimetazidina
UY36306A (es) Sintesis de ent-progesterona e intermediarios de la misma
EA201691465A1 (ru) Средство для лечения сердечно-сосудистых заболеваний